Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.77
-0.9200-19.62%
Post-market: 3.800.0300+0.80%19:59 EDT
Volume:23.21M
Turnover:96.47M
Market Cap:408.00M
PE:-1.88
High:4.75
Open:4.71
Low:3.64
Close:4.69
52wk High:8.26
52wk Low:2.19
Shares:108.22M
Float Shares:78.79M
Volume Ratio:3.70
T/O Rate:29.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-2.0100
ROE:-60.27%
ROA:-33.29%
PB:1.47
PE(LYR):-1.88

Loading ...

Rocket Pharmaceuticals Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Feb 27

Cantor Fitzgerald Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Feb 27

Balanced View on RCKT: Clinical Progress Offsetting Execution and Regulatory Risks Supports Hold Rating

TIPRANKS
·
Feb 27

Rocket Pharmaceuticals Q4 EPS $(0.38) Beats $(0.44) Estimate

Benzinga
·
Feb 27

Rocket Pharma FY 2025 net loss USD 223.1 million (-22.8%)

Reuters
·
Feb 27

Rocket Pharmaceuticals Currently Up Nine Days Straight, On Pace for Longest Winning Streak Since August 2018 -- Data Talk

Dow Jones
·
Feb 26

Rocket Pharmaceuticals to Present at TD Cowen and Leerink Partners Healthcare Conferences

Reuters
·
Feb 23

Rocket Pharmaceuticals Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
Feb 23

Rocket Pharmaceuticals Director Elisabeth Bjork Acquires Common Shares

Reuters
·
Jan 07

Rocket Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 05

Rocket Pharmaceuticals Seen With Continued Progress in 2026 -- Market Talk

Dow Jones
·
Jan 03

Rocket Pharmaceuticals CEO to Join Evercore Healthcare Conference Fireside Chat

Reuters
·
Nov 25, 2025

Rocket Pharmaceuticals CEO Gaurav Shah Reports Sale of Common Shares

Reuters
·
Nov 21, 2025

Rocket Pharmaceuticals Shares Lower After JPMorgan Downgrade

MT Newswires Live
·
Nov 19, 2025

Rocket Pharmaceuticals Is Maintained at Buy by B of A Securities

Dow Jones
·
Nov 19, 2025

JPMorgan Downgrades Rocket Pharmaceuticals to Underweight From Neutral

MT Newswires Live
·
Nov 18, 2025

Rocket Pharmaceuticals (RCKT) Receives a Buy from Bank of America Securities

TIPRANKS
·
Nov 18, 2025

Rocket Pharmaceuticals Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS
·
Nov 18, 2025

Cantor Fitzgerald Sticks to Its Buy Rating for Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Nov 07, 2025

Rocket Pharmaceuticals Q3 EPS $(0.45) Beats $(0.52) Estimate

Benzinga
·
Nov 07, 2025